Suppr超能文献

基于临床应用特点的中药复方创新药物疗效评价思路与方法探讨

[Discussion on efficacy evaluation thought and method for innovation medicine of Chinese herbal compound formula based on clinical application characteristics].

作者信息

Sun Jian-Ning, Sun Wen-Yan, Dong Shi-Fen

机构信息

Department of Pharmacology, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 100102, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(5):852-855. doi: 10.19540/j.cnki.cjcmm.20170103.023.

Abstract

The Chinese herbal compound formula preparation was made based on theory of Chinese medicine, which was confirmed by long period clinical application, and with multi-compound and multi-target characteristics. During the exploitation process of innovation medicine of Chinese herbal compound formula, selecting and speeding up the research development of drugs with clinical value shall be paid more attention, and as request of rules involved in new drug research and development, the whole process management should be carried out, including project evaluation, manufacturing process determination, establishment of quality control standards, evaluation for pharmacological and toxic effect, as well as new drug application process. This reviews was aimed to give some proposals for pharmacodynamics research methods involved in exploration of Chinese herbal compound formula preparation, including: ①the endpoint criteria should meet the clinical attribution of new drugs; ②the pre-clinical pharmacodynamics evaluation should be carried on appropriate animal models according to the characteristics of diagnosis and therapy of Chinese medicine and observation indexes; ③during the innovation of drug for infants and children, information on drug action conforming to physiological characteristics of infants and children should be supplied, and the pharmacodynamics and toxicology research shall be conducted in immature rats according to the body weight of children. In a summary, the clinical application characteristics are the important criteria for evaluation of pharmacological effect of innovation medicine of Chinese herbal compound formula.

摘要

中药复方制剂是依据中医理论制成的,经过长期临床应用验证,具有多成分、多靶点的特点。在中药复方制剂创新药物的研发过程中,应更加注重筛选和加快具有临床价值药物的研发,按照新药研发相关规定要求,进行全过程管理,包括项目评估、生产工艺确定、质量控制标准制定、药理毒效评价以及新药申报等过程。本综述旨在针对中药复方制剂研发中涉及的药效学研究方法提出一些建议,包括:①终点指标应符合新药的临床属性;②临床前药效学评价应根据中医诊疗特点和观察指标选用合适的动物模型;③在儿童用药创新过程中,应提供符合儿童生理特点的药物作用信息,并根据儿童体重在未成熟大鼠上进行药效学和毒理学研究。总之,临床应用特点是评价中药复方制剂创新药物药理作用的重要标准。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验